These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9488096)

  • 21. Sulfasalazine crystalluria-induced anuric renal failure.
    DeMichele J; Rezaizadeh H; Goldstein JI
    Clin Gastroenterol Hepatol; 2012 Feb; 10(2):A32. PubMed ID: 21982969
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
    Horikawa Y; Gu J; Wu X
    Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug induced intracranial hypertension associated with sulphasalazine treatment.
    Sevgi E; Yalcin G; Kansu T; Varli K
    Headache; 2008 Feb; 48(2):296-8. PubMed ID: 18070060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphic NATs and cancer predisposition.
    Hirvonen A
    IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pulmonary adverse effects caused by salazosulfapyridine].
    Kromann-Andersen H
    Ugeskr Laeger; 1998 Mar; 160(14):2131-2. PubMed ID: 9604688
    [No Abstract]   [Full Text] [Related]  

  • 28. Idiopathic intracranial hypertension associated with sulphasalazine treatment.
    Nawashiro H
    Headache; 2008 Oct; 48(9):1383-4. PubMed ID: 18647179
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulphasalazine induced three-week syndrome.
    Suresh R; Gupta S; Sathananthan R
    J Clin Rheumatol; 2009 Sep; 15(6):311-2. PubMed ID: 19734741
    [No Abstract]   [Full Text] [Related]  

  • 30. Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder.
    Tsai FJ; Chang CH; Chen CC; Hsia TC; Chen HY; Chen WC
    BJU Int; 2005 Feb; 95(3):432-5. PubMed ID: 15679809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.
    Kim EJ; Jeong P; Quan C; Kim J; Bae SC; Yoon SJ; Kang JW; Lee SC; Jun Wee J; Kim WJ
    Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
    Savastano M; Marioni G; Bernini G; Punzi L
    Acta Otolaryngol; 2005 Jun; 125(6):671-3. PubMed ID: 16076720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agranulocytosis associated with sulphasalazine therapy.
    Cochrane P; Atkins P; Ehsanullah S
    Postgrad Med J; 1973 Sep; 49(575):669-72. PubMed ID: 4151092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of N-acetyltransferase phenotype in development of bladder neoplasms].
    Wolf H; Lower GM; Bryan GT
    Ugeskr Laeger; 1980 Feb; 142(6):382-5. PubMed ID: 7368384
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic association with bladder cancer.
    Wolf H
    Br Med J; 1979 Nov; 2(6201):1366. PubMed ID: 519454
    [No Abstract]   [Full Text] [Related]  

  • 36. Bladder carcinoma in a teen-aged girl.
    WALLER JI; ROLL WA
    J Urol; 1957 Dec; 78(6):764-6. PubMed ID: 13482077
    [No Abstract]   [Full Text] [Related]  

  • 37. Five-aminosalicylic Acid: an update for the reappraisal of an old drug.
    Perrotta C; Pellegrino P; Moroni E; De Palma C; Cervia D; Danelli P; Clementi E
    Gastroenterol Res Pract; 2015; 2015():456895. PubMed ID: 25685145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine.
    Filiadis IF; Georgiou IA; Giannakopoulos X
    Br J Urol; 1998 Feb; 81(2):342-3. PubMed ID: 9488096
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine.
    Espin Jaime MT; Moran Penco JM; Garcia Agundez JA; Caballero Loscos MJ; Sanjuan Rodriguez S; Botello Martinez F; Gomez de Tbjada R; Laguna Alvarez E; Benitez Rodriguez I
    Br J Urol; 1997 Jul; 80(1):151-2. PubMed ID: 9240200
    [No Abstract]   [Full Text] [Related]  

  • 40. [The acetylator phenotype in patients with urinary bladder cancer].
    Wich H; Franke G; Grimm U; Siegmund W
    Z Urol Nephrol; 1989 Nov; 82(11):597-9. PubMed ID: 2618184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.